Cutting-edge enzymes from Norway
ArcticZymes Technologies has a long history dating back to the late 1980s. Based in Tromsø, Northern Norway, we use access to the marine Arctic to identify new cold-adapted enzymes for use in molecular research, in vitro diagnostics and therapeutics. We focus on strong and reliable relationships with our business partners and commercial innovators around the world. Therefore, we are constantly striving to work at the highest level and not only meet but exceed the expectations of our partners.
Our no-compromises approach ensures that our enzymes are robustly and reproducibly manufactured to deliver highly consistent products you can rely on. Our product development, manufacturing, sales and marketing processes are therefore certified and in accordance to the ISO13485 quality standard.
Download our ISO certificate now.
A partner you can count on
Security of supply
Unique enzyme features
Enzymes play a decisive role in molecular research, in vitro diagnostics and therapeutics. This makes it all the more important that they have a consistently high quality. Our novel enzymes are reproducible and have unique properties that make them particularly robust.
Direct access to unique and diverse resources for bioprospecting allows us to continuously develop novel enzyme technologies with unique features and make them available to our partners.
In the service of science
The knowledge of the important role our enzymes play in research, diagnostics and therapeutics drives us every day. Our team of highly motivated and experienced scientists is constantly developing further innovations in order to expand our portfolio of novel and high-quality solutions.
With our daily work we want to make an important contribution to a healthier world. Driven by this goal, our experienced scientists are constantly working to find and unlock new solutions.
As experts in our field, we discover, develop and provide enzymes without compromises on a consistently high level to make our customers' lives easier by unlocking new solutions.